Over a billion people are affected by fungal infections every year, ranging in severity from topical
skin conditions like athlete’s foot to life-threatening fungal blood infections.
The infection is more likely to occur when the body’s immune system is compromised due to an illness like HIV/AIDS, cancer or when receiving antibiotic treatment. There is a pressing need to develop efficient and disease-specific antifungal agents to mitigate this growing drug resistance problem. Traditional